Asensus Surgical Inc. (ASXC) News

Asensus Surgical Inc. (ASXC): $0.27

0.01 (-2.55%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Filter ASXC News Items

ASXC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ASXC News Highlights

  • For ASXC, its 30 day story count is now at 2.
  • Over the past 16 days, the trend for ASXC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • DEC are the most mentioned tickers in articles about ASXC.

Latest ASXC News From Around the Web

Below are the latest news stories about ASENSUS SURGICAL INC that investors may wish to consider to help them evaluate ASXC as an investment opportunity.

Asensus Announces Sale of Senhance Robotic System in Romania

Senhance® System to be placed at a pediatric hospital in Timisoara, Romania Senhance Surgical System The Senhance Surgical System was developed to address the challenges of pediatric surgery while preserving the benefits of minimally invasive surgery. RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced the sale of a Senhance® Surgical Syst

Yahoo | December 20, 2023

3 Stocks at the Forefront of Medical Robotics

Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy.

Josh Enomoto on InvestorPlace | December 10, 2023

Senhance Robotic System Sold by Asensus Surgical

Senhance® System to be placed at a hospital in the Commonwealth of Independent States Senhance Surgical System The Senhance Surgical System is the only commercially available robotic surgery system with haptic feedback, a differentiating feature for surgeons. RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between the surgeon and patient, announced that a Senhance® Surgical System has

Yahoo | December 4, 2023

Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023

RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2023. Recent Highlights 17% growth in surgical procedures, with over 2,700 procedures performed globally year to date at September 30, 2023Two Senhance Surgical programs

Yahoo | November 14, 2023

Asensus Surgical Announces Sale of Senhance Robotic System

Senhance® System to be placed at a pediatric hospital in the Commonwealth of Independent States Senhance Robotic System A Senhance Surgical System will be placed in a pediatric hospital in the Commonwealth of Independent States (CIS) region. RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between the surgeon and the patient, announced that a Senhance® Surgical System was sold to the Co

Yahoo | November 14, 2023

Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical System

RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced an agreement with diversified manufacturer Flex (NASDAQ: FLEX) for design and advanced manufacturing services for Asensus’s previously-announced LUNA Surgical System, a next-generation surgical robot platform. Flex will provide

Yahoo | November 13, 2023

Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 14, 2023

RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient announced today that it plans to release 2023 third quarter financial and operating results after the market closes on Tuesday, November 14, 2023. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast. To lis

Yahoo | November 7, 2023

Asensus Surgical Announces Klinikum Idar-Oberstein Hospital in Germany to Initiate Senhance Surgery Program

Expanding Minimally Invasive Surgery in Germany Senhance Surgical System The Senhance Surgical System is designed to increase surgeon control and reduce variability through Augmented Intelligence and deep learning capabilities. RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced that Klinikum Idar-Oberstein Hospital located in Germany,

Yahoo | November 6, 2023

Why Did AMC Stock Just Hit a Record Low?

AMC Entertainment (AMC) stock just hit a new low on Thursday as the movie theater company continues to step on investors' toes.

William White on InvestorPlace | September 7, 2023

Why Is Asensus Surgical (ASXC) Stock Up 18% Today?

Asensus Surgical (ASXC) stock is rising higher on Thursday as investors react to news of a collaboration with Nvidia NVDA).

William White on InvestorPlace | September 7, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!